EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Hemoperfusion with CytoSorb®: Current Knowledge on Patient Selection, Timing, and Dosing

Gerd Klinkmann, Sebastian Koball, Daniel A Reuter, Steffen Mitzner

Contributions to Nephrology · 2023

DOI: 10.1159/000527774 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Contributions to Nephrology, 2023. Verfasst von Gerd Klinkmann und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University of Rostock, Rostock, Germany. Hauptthemen laut MEDLINE: Shock, Septic, Hemoperfusion, Sepsis. Die Arbeit wurde bisher 11-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shock, SepticHemoperfusionSepsisHumansPatient SelectionCytokines

Substanzen

Cytokines

Autor:innen und Institutionen

  • Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University of Rostock, Rostock, Germany.
  • Fraunhofer Institute for Cell Therapy and Immunology, Department of Extracorporeal Therapy Systems, Rostock, Germany.
  • Department of Medicine, Division of Nephrology, Medical Faculty, University of Rostock, Rostock, Germany.

Zitieren

APA

Klinkmann, G., Koball, S., Reuter, D. A., & Mitzner, S. (2023). Hemoperfusion with CytoSorb®: Current Knowledge on Patient Selection, Timing, and Dosing. Contributions to Nephrology. https://doi.org/10.1159/000527774

Vancouver

Klinkmann G, Koball S, Reuter DA, Mitzner S. Hemoperfusion with CytoSorb®: Current Knowledge on Patient Selection, Timing, and Dosing. Contributions to Nephrology. 2023. doi:10.1159/000527774

BibTeX
@article{Klinkmann2023,
  author = {Klinkmann, Gerd and Koball, Sebastian and Reuter, Daniel A and Mitzner, Steffen},
  title = {Hemoperfusion with CytoSorb®: Current Knowledge on Patient Selection, Timing, and Dosing},
  journal = {Contributions to Nephrology},
  year = {2023},
  doi = {10.1159/000527774}
}
Kostenlos starten →